Skip to content


You currently have no items in your basket.

Antibody Report 2020

Put together by Pivotal Scientific Ltd

In 2019, Pivotal Scientific performed an analysis of the research reagent market. Using industry forecasts and our own internal knowledge of the market, we estimated that the global market for research antibodies was worth USD 1.5 billion in 2019, and the global market for research reagents reached USD 3.1 billion.

We expected future growth at a compound annual growth rate (CAGR) of between 4% - 6.5%, with growth rates varying on a regional basis, but with the onset of the COVID-19 pandemic in December 2019 causing a global shutdown, this predicted market growth may not be reached. The industry as a whole has reported a major loss in revenue, in-part caused by supply chain issues, along with both manufacturing and research laboratories ceasing or reducing operations at least temporarily.

As this is written, the full financial impact of the pandemic on research reagent companies is unknown. Diagnostic companies and those able to manufacture products related to the diagnosis, treatment, or cure (by the development of a vaccine) of COVID-19 have been able to benefit from additional interest in these products. COVID-19 has certainly brought science and the importance of scientific research to the forefront of people’s minds. The hope is that this is translated into additional funding down the line.   

The product related information in this section, highlighting customer demand within the research antibody market, should provide an invaluable guide for making informed decisions on antibody portfolio content. For the whole report please contact us at